Ethyl 2-morpholino-1,3-thiazole-4-carboxylate, 97%, 5g

Octan-2-ol, 95.0%, 500g

1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborole-5-carboxylic acid, 98%, 10g

TERT-BUTYL (3S,4R)-3-AMINO-4-{[(BENZYLOXY)CARBONYL]AMINOPIPERIDINE-1-CARBOXYLATE, 95%, 5g

EDTA magnesium disodium salt x H2O, min. 90%, for synthesis, 250 g, plastic packaging.

4-BROMO-1-(BROMOMETHYL)-2-METHOXYBENZENE, 95.0%, 250mg

3-(benzyloxy)propanenitrile, 96%, 10g

SCIADOPITYSIN, 95%, 1mg

3-methyl-6-oxo-1-phenyl-1H,2H,6H-pyrazolo[3,4-b]pyridine-5-carbonitrile, 95%, 250mg

N-ethyl-2,2,2-trifluoroethanamine hydrochloride, 95.0%, 100mg

tert-Butyl 3,3-dimethyl-4-oxopyrrolidine-1-carboxylate, 95%, 1g

2-Methyl-4-nitro-2H-indazole, 95.0%, 10g

2,5-Dibromo-6-methyl pyridine, 96.0%, 1g